结合一下Moderna老板的发言新变种的影响后续可能会扩大

老哥这炒股看起来就专业。

这界面看起来就高大上

我只在公募基金经理那边看到过[s:ac:哭笑] 富国，汇添富

有点专业

Moderna老板应该参与到控盘了，真的可以说是纯畜牲了

楼主真富啊，能用的起彭博[img]http://img.nga.178.com/attachments/mon_201209/14/-47218_5052bc4cc6331.png[/img]

对面长荣也是成交量放大
[img]https://img.nga.178.com/attachments/mon_202111/30/jmQ2p-gm9xXhZ4oT3cSzk-qo.jpg.medium.jpg[/img]

海运板块走势喜人

如果真的这么严重，那市场应该预估会继续放水啊[s:ac:晕]
他们跑啥呢？

老哥id在我收藏夹里[s:ac:心]就为了偶尔蹭下彭博终端

[quote][pid=569920047,29655305,1]Reply[/pid] Post by [uid=62743826]xmlond[/uid] (2021-11-30 14:43):

老哥id在我收藏夹里[s:ac:心]就为了偶尔蹭下彭博终端[/quote]哈哈，多谢捧场 想多来贴贴彭博新闻稿来着 又怕没什么人看

彭博终端？ 牛逼啊 一看LZ就是大佬

[quote][pid=569920047,29655305,1]Reply[/pid] Post by [uid=62743826]xmlond[/uid] (2021-11-30 14:43):

老哥id在我收藏夹里[s:ac:心]就为了偶尔蹭下彭博终端[/quote]好家伙，遇到跟我一样白嫖的了

牛逼 [s:ac:哭笑]

新冠疫情追踪：香港扩大限制；新加坡重新开放起步艰难
彭博新闻社报道
[彭博]--?随着新冠病毒变异毒株omicron的传播，香港加入了世界各地扩大旅行限制的行列。甚至在新变异毒株出现之前，新加坡期待已久的重新开放所吸引的游客依然少得出人意料。
中国承诺向非洲国家再提供10亿剂疫苗。美国总统乔·拜登告诫美国人不要恐慌，并敦促他们接种疫苗或加强针。美国疾病控制与预防中心将接种加强针的建议扩大到所有成年人。
曾提醒政府科学家注意新毒株可能性的南非医生表示，她发现omicron感染者症状较轻。但是世界卫生组织警告，Omicron毒株或导致感染人数激增并带来“严重后果”。

[img]https://img.nga.178.com/attachments/mon_202111/30/jmQ2p-94oyXfZ46T3cSzk-qo.jpg.medium.jpg[/img]

三大航运，tw三杰与韩梅梅近六个月的走势 汇总

Moderna CEO Sparks Slump Reiterating Omicron May Need New Shots

(Bloomberg) -- The plethora of mutations in the omicron variant are likely to help it evade the protection provided by existing vaccines, making it necessary to develop new immunizations, Moderna Inc. Chief Executive Officer Stephane Bancel told the Financial Times, triggering a pullback in risk assets.

Bancel effectively reiterated comments made by Moderna’s Chief Medical Officer Paul Burton at the weekend, that omicron may elude current vaccines, and if so, a reformulated shot would be available early in the new year. The CEO seemed to damp expectations new vaccines could be ready soon, however, saying in the FT interview it may take months for pharmaceutical companies to develop and deploy updated immunizations that they can deliver in large numbers.
There is no way the current shots will provide the same level of protection against omicron as they do against delta, and there will be a material drop in their efficacy, he said.
“I just don’t know how much because we need to wait for the data,” Bancel was quoted as saying. “All the scientists I’ve talked to . . . are like ‘this is not going to be good”’

Bancel’s definitiveness appeared to spook markets, with stocks in Asia retreating along with U.S. and European index futures and crude oil.

Stocks, Futures Hit by Vaccine Worry as Bonds Jump: Markets Wrap
Moderna said last week that it has already been studying booster shots that were designed to anticipate mutations such as those that have emerged in the omicron variant and will rapidly advance a candidate targeting this new strain specifically.
Stephane Bancel on May 12.

Current vaccines from developers including Moderna, Pfizer Inc. and BioNTech SE, AstraZeneca Plc and Johnson & Johnson are all able to help reduce the risk of severe infection and death from previous strains of the virus, though they work less well against the more transmissible delta variant.

Research is still underway to determine if omicron causes the same level of illness as older versions of the virus, if it can evade protection from vaccines and previous infections, and if it will be able to outcompete the existing strains as the pathogen continues to circulate throughout the world.

Moderna is striking a more pessimistic tone than Pfizer, with Chief Executive Officer Albert Bourla saying earlier in an interview with Bloomberg Television that omicron will know in two to three weeks how well its current shot holds up against omicron, and even in a worst-case scenario he expects the existing formula will retain some efficacy against the heavily mutated strain.

Bourla said Pfizer will be ready with a vaccine targeting omicron in 100 days, should it be necessary.

Chinese vaccine maker Sinovac Biotech Ltd, whose inactivated Covid shot has been widely used in China and much of the developing world, said it’s also evaluating its vaccine’s performance against omicron and the necessity for a new shot. The company said it can rapidly come up a new vaccine and manufacture it at scale quickly. Meanwhile, Chinese company CanSino Biologics Inc and Japanese drugmaker Shionogi & Co have both said they’re working on new vaccines for the variant.

贴点热乎的 看起来子弹还能再飞一会儿

[img]https://img.nga.178.com/attachments/mon_202111/30/jmQ2p-fb5pXiZ4zT3cSzk-qo.jpg.medium.jpg[/img]
[img]https://img.nga.178.com/attachments/mon_202111/30/jmQ2p-5368XhZ4sT3cSzk-qo.jpg.medium.jpg[/img]

日韩hk大盘受消息影响跌幅都不小

辛苦辛苦[s:ac:茶]

彭博的价格据说很高[s:ac:瞎][s:ac:瞎]
老哥这每天可以来个复盘

直接说吧，利好什么？